1. Home
  2. OLMA vs ONTO Comparison

OLMA vs ONTO Comparison

Compare OLMA & ONTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • ONTO
  • Stock Information
  • Founded
  • OLMA 2006
  • ONTO 1940
  • Country
  • OLMA United States
  • ONTO United States
  • Employees
  • OLMA N/A
  • ONTO N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • ONTO Industrial Machinery/Components
  • Sector
  • OLMA Health Care
  • ONTO Industrials
  • Exchange
  • OLMA Nasdaq
  • ONTO Nasdaq
  • Market Cap
  • OLMA 465.4M
  • ONTO 8.0B
  • IPO Year
  • OLMA 2020
  • ONTO N/A
  • Fundamental
  • Price
  • OLMA $6.10
  • ONTO $167.30
  • Analyst Decision
  • OLMA Strong Buy
  • ONTO Strong Buy
  • Analyst Count
  • OLMA 5
  • ONTO 8
  • Target Price
  • OLMA $26.25
  • ONTO $254.29
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • ONTO 694.2K
  • Earning Date
  • OLMA 11-12-2024
  • ONTO 02-06-2025
  • Dividend Yield
  • OLMA N/A
  • ONTO N/A
  • EPS Growth
  • OLMA N/A
  • ONTO 16.27
  • EPS
  • OLMA N/A
  • ONTO 3.70
  • Revenue
  • OLMA N/A
  • ONTO $942,238,000.00
  • Revenue This Year
  • OLMA N/A
  • ONTO $23.06
  • Revenue Next Year
  • OLMA N/A
  • ONTO $16.73
  • P/E Ratio
  • OLMA N/A
  • ONTO $45.19
  • Revenue Growth
  • OLMA N/A
  • ONTO 10.81
  • 52 Week Low
  • OLMA $5.56
  • ONTO $134.11
  • 52 Week High
  • OLMA $16.78
  • ONTO $238.93
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • ONTO 45.31
  • Support Level
  • OLMA $5.56
  • ONTO $163.45
  • Resistance Level
  • OLMA $6.87
  • ONTO $182.34
  • Average True Range (ATR)
  • OLMA 0.81
  • ONTO 6.04
  • MACD
  • OLMA -0.28
  • ONTO 1.14
  • Stochastic Oscillator
  • OLMA 10.12
  • ONTO 26.71

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About ONTO Onto Innovation Inc.

Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the largest sources of total revenue.

Share on Social Networks: